Design of potent thiophene inhibitors of polo-like kinase 1 with improved solubility and reduced protein binding
- 15 March 2009
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 19 (6), 1694-1697
- https://doi.org/10.1016/j.bmcl.2009.01.094
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Discovery of thiophene inhibitors of polo-like kinaseBioorganic & Medicinal Chemistry Letters, 2009
- Tubulin-associated proteins: Aurora and Polo-like kinases as therapeutic targets in cancerCurrent Oncology Reports, 2008
- In vitro biological activity of a novel small-molecule inhibitor of polo-like kinase 1Molecular Cancer Therapeutics, 2007
- Progress in the Discovery of Polo-like Kinase InhibitorsCurrent Topics in Medicinal Chemistry, 2005
- Polo-like kinases (Plks) and cancerOncogene, 2005
- Polo-like kinases and the orchestration of cell divisionNature Reviews Molecular Cell Biology, 2004
- Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cellsProceedings of the National Academy of Sciences, 2003
- Tumor regression by combination antisense therapy against Plk1 and Bcl-2Oncogene, 2003
- The Functions of Polo-Like Kinases and their Relevance to Human DiseaseCurrent Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents, 2002
- Polo-like kinases: a team that plays throughout mitosisGenes & Development, 1998